Fatty acid metabolism and drug resistance to EZH2 inhibition

Detalles Bibliográficos
Autor principal: Wang, Yemin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897622/
https://www.ncbi.nlm.nih.gov/pubmed/35248993
http://dx.doi.org/10.1016/j.ebiom.2022.103916
_version_ 1784663459538927616
author Wang, Yemin
author_facet Wang, Yemin
author_sort Wang, Yemin
collection PubMed
description
format Online
Article
Text
id pubmed-8897622
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88976222022-03-06 Fatty acid metabolism and drug resistance to EZH2 inhibition Wang, Yemin EBioMedicine Commentary Elsevier 2022-03-03 /pmc/articles/PMC8897622/ /pubmed/35248993 http://dx.doi.org/10.1016/j.ebiom.2022.103916 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Wang, Yemin
Fatty acid metabolism and drug resistance to EZH2 inhibition
title Fatty acid metabolism and drug resistance to EZH2 inhibition
title_full Fatty acid metabolism and drug resistance to EZH2 inhibition
title_fullStr Fatty acid metabolism and drug resistance to EZH2 inhibition
title_full_unstemmed Fatty acid metabolism and drug resistance to EZH2 inhibition
title_short Fatty acid metabolism and drug resistance to EZH2 inhibition
title_sort fatty acid metabolism and drug resistance to ezh2 inhibition
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897622/
https://www.ncbi.nlm.nih.gov/pubmed/35248993
http://dx.doi.org/10.1016/j.ebiom.2022.103916
work_keys_str_mv AT wangyemin fattyacidmetabolismanddrugresistancetoezh2inhibition

Ejemplares similares